A CURRENT CONSTRICTION PHENOMENON IN HIGH CURRENT VACUUM ARCSSCHELLEKENS H.1981; PHYSICA B+C; ISSN 0378-4363; NLD; DA. 1981; VOL. 104; NO 1-2; PP. 130-136; BIBL. 7 REF.Conference Paper

Assessing the bioequivalence of biosimilars : The Retacrift® caseSCHELLEKENS, H.Drug discovery today. 2009, Vol 14, Num 9-10, pp 495-499, issn 1359-6446, 5 p.Article

When biotech proteins go off-patentSCHELLEKENS, H.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 8, pp 406-410, issn 0167-7799, 5 p.Article

PROPHYLAXIS AND THERAPY OF HBSAG POSITIVE HEPATITISWEIMAR W; SCHELLEKENS H.1979; BIOMEDECINE; FRA; DA. 1979; VOL. 30; NO 3; PP. 135-138; ABS. FRE; BIBL. 41 REF.Article

The diffuse vacuum arc: a definitionSCHELLEKENS, H.IEEE transactions on plasma science. 1985, Vol 13, Num 5, pp 291-295, issn 0093-3813Article

SIMPLE METHOD FOR MEASURING GROWTH INHIBITION BY INTERFERON OF CELLS IN MONOLAYERSCHELLEKENS H; STITZ LW.1980; J. VIROL. METHODS; NLD; DA. 1980; VOL. 1; NO 4; PP. 197-200; BIBL. 6 REF.Article

A FUTURE FOR EXOGENOUS INTERFERON THERAPY.WEIMAR W; SCHELLEKENS H.1979; NETHERLAND. J. MED.; NLD; DA. 1979; VOL. 21; NO 6; PP. 275-278; BIBL. 31 REF.Article

The high-current vacuum arc in an axial magnetic field: an experimental investigationSCHELLEKENS, H.Journal of applied physics. 1983, Vol 54, Num 1, pp 144-149, issn 0021-8979Article

INFLUENCE OF INPUT MULTIPLICITY OF INFECTION ON THE ANTIVIRAL ACTIVITY OF INTERFERONSTITZ L; SCHELLEKENS H.1980; J. GEN. VIROL.; GBR; DA. 1980; VOL. 46; NO 1; PP. 205-210; BIBL. 22 REF.Article

INDUCTION OF NATURAL KILLER CELL ACTIVITY AND ALLOCYTOTOXICITY IN HUMAN PERIPHERAL BLOOD LYMPHOCYTES AFTER MIXED LYMPHOCYTE CULTUREBOLHUIS RLH; SCHELLEKENS H.1981; SCAND. J. IMMUNOL.; ISSN 0300-9475; NOR; DA. 1981; VOL. 13; NO 5; PP. 401-412; BIBL. 40 REF.Article

ANTIVIRAL AND SIDE EFFECTS OF INTERFERONS PRODUCED BY RECOMBINANT DNA TECHNIQUES AS TESTED IN RHESUS MONKEYSSCHELLEKENS H; VAN EERD PMCA.1982; ANTIVIR. RES.; ISSN 0166-3542; NLD; DA. 1982; VOL. 2; NO 5; PP. 313-318; BIBL. 11 REF.Article

THE INFLUENCE OF EMETINE ON THE INDUCTION OF INTERFERON BY POLY-I: POLY-C IN SWISS MICESCHELLEKENS H; HUFFMEYER JHPM; VANGRIENSVEN LJLD et al.1975; J. GEN. VIROL.; G.B.; DA. 1975; VOL. 26; NO 2; PP. 197-200; BIBL. 8REF.Article

PRODUCTION AND INITIAL CHARACTERIZATION OF RAT INTERFERONSCHELLEKENS H; DE WILDE GA; WEIMAR W et al.1980; J. GEN. VIROL.; GBR; DA. 1980; VOL. 46; NO 1; PP. 243-247; BIBL. 13 REF.Article

Current and voltage distribution in the diffuse vacuum arcSCHELLEKENS, H; SCHRAM, D. C.IEEE transactions on plasma science. 1985, Vol 13, Num 5, pp 261-264, issn 0093-3813Article

EFFECT OF TREATMENT WITH INTERFERON AND CYCLOPHOSPHAMIDE ON THE GROWTH OF A SPONTANEOUS LIPOSARCOMA IN RATS = EFFET DU TRAITEMENT AVEC L'INTERFERON ET LE CYCLOPHOSPHAMIDE SUR LA CROISSANCE D'UN LIPOSARCOME SPONTANE CHEZ LES RATSMARQUET RL; SCHELLEKENS H; WESTBROEK DL et al.1983; INTERNATIONAL JOURNAL OF CANCER; ISSN 0020-7136; CHE; DA. 1983; VOL. 31; NO 2; PP. 223-226; ABS. ENG; BIBL. 17 REF.; GRAPHArticle

Immunogenicity of biopharmaceuticals. The european perspectiveSCHELLEKENS, H; CASADEVALL, N.Developments in biologicals. 2003, Vol 112, pp 23-28, issn 1424-6074, 6 p.Article

PREVENTION OF VACCINIA LESIONS IN RHESUS MONKEYS BY HUMAN LEUCOCYTE AND FIBROBLAST INTERFERONWEIMAR W; STITZ L; BILLIAU A et al.1980; J. GEN. VIROL.; GBR; DA. 1980; VOL. 48; NO 1; PP. 25-30; BIBL. 18 REF.Article

DIFFERENTIAL EFFECTS OF FIBROBLAST AND LEUCOCYTE INTERFERON IN HBSAG POSITIVE CHRONIC ACTIVE HEPATITISWEIMAR W; HEIJTINK RA; SCHALM SW et al.1979; EUROP. J. CLIN. INVEST.; DEU; DA. 1979; VOL. 9; NO 2 PART. 1; PP. 151-154; BIBL. 18 REF.Article

Visualization and characterization of high-current diffuse vacuum arcs on axial magnetic field contactsSCHULMAN, M. B; SCHELLEKENS, H.IEEE transactions on plasma science. 2000, Vol 28, Num 2, pp 443-452, issn 0093-3813Article

INFLUENCE OF INTERFERON PREPARATIONS ON THE PROLIFERATIVE CAPACITY OF HUMAN AND MOUSE BONE MARROW CELLS IN VITRO.VAN'THULL E; SCHELLEKENS H; LOEWENBERG B et al.1978; CANCER. RES.; U.S.A.; DA. 1978; VOL. 38; NO 4; PP. 911-914; BIBL. 19 REF.Article

The immunogenicity of biopharmaceuticals: Lessons learned and consequences for protein drug developmentPATTEN, Pa; SCHELLEKENS, H.Developments in biologicals. 2003, Vol 112, pp 81-97, issn 1424-6074, 17 p.Article

Arc behaviour in axial magnetic field vacuum interrupters equipped with an external coilSCHELLEKENS, H.International symposium on discharges and electrical insulation in vacuum. 1998, isbn 0-7803-3953-3, 2Vol, Vol 2, 514-517Conference Paper

The origin of current constriction in vacuum arcsSCHELLEKENS, H; SCHRAMN, D. C.Physics letters. A. 1984, Vol 100, Num 2, pp 88-90, issn 0375-9601Article

ANTIVIRAL EFFECT OF INTERFERON IN VIVO MAY BE MEDIATED BY THE HOSTSCHELLEKENS H; WEIMAR W; CANTELL K et al.1979; NATURE; GBR; DA. 1979; VOL. 278; NO 5706; PP. 742; BIBL. 7 REF.Article

DIFFERENTIAL SENSITIVITY OF RAUSCHER MURINE LEUKAEMIA VIRUS (MULV-R) TO INTERFERONS IN TWO INTERFERON-RESPONSIVE CELL LINESALLEN PT; SCHELLEKENS H; VAN GRIENSVEN LJLD et al.1976; J. GEN. VIROL.; G.B.; DA. 1976; VOL. 31; NO 3; PP. 429-435; BIBL. 19 REF.Article